SCHEMBL609524

SCHEMBL609524

CCCC(C)(C)OC(=O)OC(C)(C)CCC

nearest known ligand 0.40

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.40
HSD17B10 Q99714 1/20 0.40
GAA P10253 1/20 0.36
ALDH1A1 P00352 3/20 0.35
ELANE P08246 1/20 0.32
FDPS P14324 2/20 0.32
CES2 O00748 1/20 0.31
CA1 P00915 1/20 0.31
CA2 P00918 1/20 0.31
SOAT1 P35610 1/20 0.31
TSHR P16473 2/20 0.30
CYP3A4 P08684 1/20 0.30
NFKB1 P19838 1/20 0.30
ADRA1A P35348 1/20 0.30
RAB9A P51151 1/20 0.30
TDP1 Q9NUW8 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19010236 0.93 LMNA (0.36) LMNAHSD17B10GAAALDH1A1ELANE
SCHEMBL14245000 0.90 SOAT1 (0.39) LMNAHSD17B10GAAALDH1A1ELANE
SCHEMBL21433590 0.88 LMNA (0.36) LMNAHSD17B10GAAALDH1A1ELANE
SCHEMBL15160841 0.88 CA1 (0.41) LMNAHSD17B10GAAALDH1A1ELANE
SCHEMBL10087931 0.86 ALDH1A1 (0.50) LMNAHSD17B10GAAALDH1A1CA1
SCHEMBL608105 0.85 CA1 (0.38) LMNAHSD17B10GAAALDH1A1FDPS
SCHEMBL25110155 0.84 LMNA (0.34) LMNAHSD17B10GAAALDH1A1SOAT1
SCHEMBL22662428 0.84 SOAT1 (0.34) LMNAHSD17B10GAAALDH1A1ELANE
SCHEMBL27338217 0.84 LMNA (0.34) LMNAHSD17B10GAAALDH1A1
SCHEMBL213107 0.84 LMNA (0.40) LMNAHSD17B10GAAALDH1A1ELANE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 115 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12463253-B2 Nonaqueous electrolyte solution secondary battery GS YUASA INTERNATIONAL LTD. (JP) 2025-11-04 US disclosed
US-20250233206-A1 NON-AQUEOUS ELECTROLYTE SOLUTION AND NON-AQUEOUS ELECTROLYTE SECONDARY BATTERY EMPLOYING THE SAME MITSUBISHI CHEMICAL CORPORATION (JP) 2025-07-17 US disclosed
US-12315883-B2 Non-aqueous electrolyte solution and non-aqueous electrolyte secondary battery employing the same MITSUBISHI CHEMICAL CORPORATION (JP) 2025-05-27 US disclosed
US-12261265-B2 Method for producing lithium fluorosulfonate, lithium fluorosulfonate, nonaqueous electrolytic solution, and nonaqueous electrolytic solution secondary battery MITSUBISHI CHEMICAL CORPORATION (JP) 2025-03-25 US disclosed
US-20230395857-A1 NON-AQUEOUS ELECTROLYTE SOLUTION AND NON-AQUEOUS ELECTROLYTE SECONDARY BATTERY EMPLOYING THE SAME MITSUBISHI CHEMICAL CORPORATION (JP) 2023-12-07 US disclosed
US-11791499-B2 Non-aqueous electrolyte solution and non-aqueous electrolyte secondary battery employing the same MITSUBISHI CHEMICAL CORPORATION (JP) 2023-10-17 US disclosed
EP-4219400-A2 METHOD FOR PRODUCING LITHIUM FLUOROSULFONATE, LITHIUM FLUOROSULFONATE, USE OF LITHIUM FLUOROSULFONATE IN A NONAQUEOUS ELECTROLYTIC SOLUTION, AND NONAQUEOUS ELECTROLYTIC SOLUTION Mitsubishi Chemical Corporation (JP) 2023-08-02 EP disclosed
EP-3528330-B1 NON-AQUEOUS ELECTROLYTE SECONDARY BATTERY MITSUBISHI CHEM CORP (JP) 2023-07-26 EP disclosed
US-11695155-B2 Non-aqueous electrolytic solution and non-aqueous electrolyte secondary battery using the same MITSUBISHI CHEMICAL CORPORATION (JP) 2023-07-04 US disclosed
US-20230155178-A1 NON-AQUEOUS ELECTROLYTIC SOLUTION AND NON-AQUEOUS ELECTROLYTE SECONDARY BATTERY USING THE SAME MITSUBISHI CHEMICAL CORPORATION (JP) 2023-05-18 US disclosed
US-20120219868-A1 NON-AQUEOUS ELECTROLYTE SECONDARY BATTERY AND NON-AQUEOUS ELECTROLYTE MITSUBISHI CHEMICAL CORPORATION (JP) 2012-08-30 US disclosed
US-8206853-B2 Non-aqueous electrolyte secondary battery and non-aqueous electrolyte SANYO ELECTRIC CO., LTD. (JP) 2012-06-26 US disclosed
US-20120045698-A1 NON-AQUEOUS LIQUID ELECTROLYTE AND NON-AQUEOUS LIQUID ELECTROLYTE SECONDARY BATTERY USING THE SAME MITSUBISHI CHEMICAL CORPORATION (JP) 2012-02-23 US disclosed
US-20120040252-A1 NON-AQUEOUS LIQUID ELECTROLYTE AND NON-AQUEOUS LIQUID ELECTROLYTE SECONDARY BATTERY USING THE SAME MITSUBISHI CHEMICAL CORPORATION (JP) 2012-02-16 US disclosed
EP-2278652-A2 Non-aqueous liquid electrolyte and non-aqueous liquid electrolyte secondary battery using the same Mitsubishi Chemical Corporation (JP) 2011-01-26 EP disclosed
US-7803487-B2 Non-aqueous liquid electrolyte and non-aqueous liquid electrolyte secondary battery using the same MITSUBISHI CHEMICAL CORPORATION (JP) 2010-09-28 US disclosed
US-20100216036-A1 NON-AQUEOUS LIQUID ELECTROLYTE AND NON-AQUEOUS LIQUID ELECTROLYTE SECONDARY BATTERY USING THE SAME MITSUBISHI CHEMICAL CORPORATION (JP) 2010-08-26 US disclosed
US-20090311609-A1 NONAQUEOUS ELECTROLYTE SECONDARY BATTERY AND NONAQUEOUS ELECTROLYTE SOLUTION SANYO ELECTRIC CO., LTD. (JP) 2009-12-17 US disclosed
US-20080102375-A1 NON-AQUEOUS LIQUID ELECTROLYTE AND NON-AQUEOUS LIQUID ELECTROLYTE SECONDARY BATTERY USING THE SAME MITSUBISHI CHEMICAL CORPORATION (JP) 2008-05-01 US disclosed
EP-1898485-A1 NONAQUEOUS ELECTROLYTE, AND RECHARGEABLE BATTERY WITH NONAQUEOUS ELECTROLYTE Mitsubishi Chemical Corporation (JP) 2008-03-12 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11695155-B2 Non-aqueous electrolytic solution and non-aqueous electrolyte secondary battery using the same PTPN1, TP53RK, VDAC1 LMNA 3940/4885HSD17B10 1903/4885GAA 3551/4885
US-20230155178-A1 NON-AQUEOUS ELECTROLYTIC SOLUTION AND NON-AQUEOUS ELECTROLYTE SECONDARY BATTERY USING THE SAME PTPN1, TP53RK, VDAC1 LMNA 3940/4885HSD17B10 1903/4885GAA 3551/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.